Menu

2014

RedHill Biopharma and Salix Pharmaceuticals Announce Worldwide Exclusive License Agreement for RedHill's RHB-106

27 March, 2014 RedHill Biopharma and Salix Pharmaceuticals Announce Worldwide Exclusive License Agreement for RedHill's RHB-106 Encapsulated Bowel Preparation

Form 6-K RedHill Biopharma Announces Closing of $8.5 Million Private Placements from OrbiMed and Broadfin

9 January, 2014